Bcs 50 Years

Named a Top Five Book of 2011 by Physics Today, USA.The BCS theory of superconductivity developed in 1957 by Bardeen, Cooper and Schrieffer has been remarkably successful in explaining the properties of superconductors. In addition, concepts from BCS have been incorporated into diverse fields of physics, from nuclear physics and dense quark matter to the current standard model. Practical applications include SQUIDs, magnetic resonance imaging, superconducting electronics and the transmission of electricity. This invaluable book is a compilation of both a historical account and a discussion of the current state of theory and experiment.With contributions from many prominent scientists, it aims to introduce students and researchers to the origins, the impact and the current state of the BCS theory.

This unique volume reviews more than fifty years of theoretical and experimental developments of the concept that properties of atomic nuclei up to a great extent are defined by the pair correlations of nuclear constituents - protons and neutrons. Such correlations in condensed matter are responsible for quantum phenomena on a macroscopic level - superfluidity and superconductivity. After introducing Bardeen-Cooper-Schrieffer (BCS) theory of superconductivity of metals, it became clear that atomic nuclei have properties of superfluid drops, and practically all features of nuclei strongly depend on the pair correlations. Presenting a comprehensive overview of the progress of nuclear science, the contributions from leading physicists around the world, cover the whole spectrum of studies in nuclear physics and physics of other small systems. With the most updated information written in an accessible way, the volume will serve as an irreplaceable source of references covering many years of development and insight into several new problems at the frontiers of science. It will be useful not only for physicists working in nuclear and condensed matter physics, astrophysicists, chemists and historians of science, but will also help students understand the current status and perspectives for the future.

This book offers a comprehensive overview of the use of breast MRI for screening high-risk women, including those with familial-genetic hereditary predisposition and previous chest radiation therapy, typically lymphoma survivors. It discusses the historical background of studies and research that provided the body of evidence in favor of MRI screening of these women. Technical and clinical topics are treated in dedicated chapters, including models for individualized risk estimation, radiogenomics of breast cancer in high-risk women, computer-aided detection/diagnosis and machine learning systems applied to breast MRI, and psycho-oncology issues. Alternatives to breast MRI screening such as pharmaco-prevention and prophylactic mastectomy are also discussed, taking into account the public debate on the “Angelina Jolie” effect. The high breast cancer risk model is proposed as a paradigm for personalized medicine. This book will be of interest to radiologists, surgeons, oncologists and to all professionals devoted to female healthcare.

Frank Wilczek is one of the foremost theoretical physicists of the past half-century. He has made several fundamental contributions that shape our understanding of high energy physics, cosmology, condensed matter physics, and statistical physics. In all these fields his many discoveries continue to play a key role in shaping the direction of modern theoretical physics.Among Wilczek's major achievements is the discovery of asymptotic freedom, which predicts and explains the ultraviolet behavior of non-abelian gauge theories. The axion, which he co-discovered and named, has emerged as the prevalent candidate for explaining the origin of dark matter in the Universe. His invention of color-flavor locking explains chiral symmetry breaking in high density quantum chromodynamics. His introduction of fractional statistics and anyons are pivotal to our understanding of the fractional quantum Hall effect and form the building blocks of topological quantum computing. His invention of the time crystal concept has catalyzed extensive investigations of dynamical phases of physical systems.Frank Wilczek received the 2004 Nobel Prize in Physics for the discovery of asymptotic freedom. He is also the recipient of several Prizes and honorary awards including the MacArthur Fellowship, the Lorentz Medal of the Royal Netherlands Academy of Arts and Sciences, the Lilienfeld Prize of the American Physical Society, the High Energy and Particle Physics Prize of the European Physical Society, and the King Faisal International Prize for Science of the King Faisal Foundation. He is a member of the National Academy of Sciences, American Academy of Arts and Sciences, and the American Philosophical Society. He is also a foreign member of the Royal Netherlands Academy of Arts and Sciences and of the Royal Academy of Sciences in Sweden.He is currently the Herman Feshbach Professor of Physics at MIT Center for Theoretical Physics. He also holds a professorship at Stockholm University, is a Distinguished Professor at Arizona State University, and is the founding director of the Tsung-Dao Lee Institute and Chief Scientist of the Wilczek Quantum Center at Shanghai Jiao Tong University.This volume serves as a tribute to Frank Wilczek's legendary scientific contributions, commemorating his 70th birthday and the first 50 years of his career as a theoretical physicist. The contributors include several of his PhD students, close collaborators, and both past and present colleagues.

Management of atypical breast lesions continues to evolve. There is considerable controversy as to whether these entities represent risk factors for future breast cancer or whether they are instead precursor lesions. A better understanding of the prognostic and therapeutic implications of each of these lesions is important for assessing subsequent breast cancer risk. Risk assessment tools are available for screening high risk patients and understanding the utility and limitations of these tools is important for all clinicians involved in the care of patients. There have been significant advances in breast cancer screening in the last several year including breast tomosynthesis, automated breast ultrasound, molecular imaging, as well as accelerated breast MRI protocols. This has raised the question: Do women at risk for breast cancer need additional breast cancer screening using these newer imaging modalities? In addition, with these advances in imaging, can women with atypical proliferative lesions be observed rather than undergoing surgical excision as some suggest? The role of observation, surgical excision and even prophylactic mastectomy in women with atypical proliferative lesions continues to be debated; however there is data that can guide physicians in the management of these patients. Pleomorphic Lobular carcinoma in-situ (PLCIS) is a distinct pathological entity within LCIS and there is no consensus regarding surgical margins or the need for adjuvant treatment to prevent recurrence. Recently, ductal carcinoma in-situ (DCIS) has been the subject of much controversy: is it truly a cancer or is it instead a precursor lesion. The traditional management of DCIS with lumpectomy and radiation is now being debated and recent data demonstrates that low grade DCIS can be managed with observation. Clinical trials are now accruing patients with low and intermediate grade DCIS to observation and close surveillance, and not surgical excision. Finally, new guidelines for chemoprevention with the use of tamoxifen and raloxifen for women with atypical proliferative lesions, LCIS, PLCIS, and DCIS are available and should be discussed as an option when guiding management of these patients. This book will provide a comprehensive review of this field and will serve as a valuable resource for clinicians, general surgeons, breast surgeons and surgical oncologists, as well as researchers with an interest in the management of atypical breast lesions. The book will review new data about breast cancer, risk factors for breast cancer, pathological features unique to each entity, the characteristic findings on imaging, risk stratification for genetic testing, as well as the current evidence-based management of each of these breast lesions. Our text will provide assessment tools for risk prediction of breast cancer. We will provide data on the current imaging modalities, as well as advanced screening options available for diagnosis and following these patients. Current management of many of these lesions continues to be controversial in regard to observation with close surveillance versus the need for surgical excision of these lesions based on future risk or whether these lesions are precursor lesion. For ductal carcinoma in-situ, the debate continues in regards to whether this disease entity is a precursor lesion that can be managed with observation or hormonal therapy, or is DCIS cancer and treated with lumpectomy and radiation. Several studies have been published where patients are managed with observation and treatment with hormonal therapy before surgical management. New trials have already begun accruing patients with low to intermediate grade DCIS where patients will be managed with observation versus hormonal therapy only. Management of DCIS continues to evolve and current management will be discussed This text will provide a concise but comprehensive summary of the current management of patients with atypical breast proliferative lesions and some benign breast lesions and will help guided management of these patients. All chapters in this text will be written by experts in the field in each of these disease entities. They will all include the most up to date research and clinical information to enhance our understanding and treatment of patients.

A Mind Over Matter is a biography of the Nobel-prize winner Philip W. Anderson, a person widely regarded as one of the most accomplished and influential physicists of the second half of the twentieth century. Anderson (1923-2020) was a theoretician who specialized in the physics of matter, including window glass and metals, magnets and semiconductors, liquid crystals and superconductors. More than any other single person, Anderson transformed the patchwork subject of solid-state physics into the deep, subtle, and coherent discipline known today as condensed matter physics. Among his many world-class research achievements, Anderson discovered an aspect of wave physics that had been missed by all previous scientists going back to Isaac Newton. He became a public figure when he testified before Congress to oppose its funding of an expensive project intended exclusively for particle physics research. Over the years, he published many articles designed to influence a broad audience about issues where science impacted public policy and culture. Anderson grew up in the American mid-west, was educated at Harvard, and rose to the pinnacle of his profession during the first decade of his thirty-five career as a theoretical physicist at Bell Telephone Laboratories. Almost uniquely, he spent many years working half-time as a professor at the University of Cambridge and at Princeton University. The outspoken Anderson enjoyed broad influence outside of physics when he helped develop and champion the concepts of emergence and complexity as organizing principles to help attack very difficult problems in technically challenging disciplines.

Radiation Oncology: Rationale, Technique, Results, by James D. Cox, MD and K. Kian Ang, MD, PhD, provides you with authoritative guidance on the latest methods for using radiotherapy to treat patients with cancer. Progressing from fundamental principles through specific treatment strategies for the cancers of each organ system, it also addresses the effects of radiation on normal structures and the avoidance of complications. This 9th edition covers the most recent indications and techniques in the field, including new developments in proton therapy and intensity-modulated radiotherapy (IMRT). It also features, for the first time, full-color images throughout the text to match those that you see in practice, and uses new color-coded treatment plans to make targets, structures, and doses easier to read at a glance. Evidence from randomized clinical trials is included whenever possible to validate clinical recommendations. The state-of-the-art coverage inside this trusted resource equips you to target cancer as effectively as possible while minimizing harm to healthy tissue. Stands apart as the only book in the field to cover the conceptual framework for the use of radiotherapy by describing the most effective techniques for treatment planning and delivery and presenting the results of each type of therapy. Emphasizes clinical uses of radiation therapy, providing pertinent, easy-to-understand information on state-of-the-art treatments. Includes information useful for non-radiotherapists, making it "recommended reading" for other oncology specialists. Offers a practical, uniform chapter structure to expedite reference. Guides you through the use of the newest radiation oncology techniques, including principles of proton therapy and new developments in intensity-modulated radiotherapy (IMRT). Incorporates evidence from randomized clinical trials whenever possible to validate clinical recommendations. Presents full-color images throughout to match the images that you see in practice. Extensive use of "combination" imaging presents a complete picture of how to more precisely locate and target the radiotherapy field.